Induction of PPARbeta and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARbeta.
about
The Role of PPARs in CancerCellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.Time course change of COX2-PGI2/TXA2 following global cerebral ischemia reperfusion injury in rat hippocampus.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In VitroThe toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and diseaseTargeting PPAR receptors in the airway for the treatment of inflammatory lung disease.Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.Development of improved PPARβ/δ inhibitors.PPARs and lipid ligands in inflammation and metabolism.Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
P2860
Q21342955-C56ED631-3B6C-4265-9F9C-1C850EED5990Q34128015-109F13D5-9C32-4A7E-8CE2-5285142D173FQ34558658-D06B5F93-A108-4A34-A3CF-2708E8931DA2Q35613331-C9528B12-622E-4DAA-8933-832661D870B8Q35920285-03736456-8457-4EBE-AFEA-91A2105ECF9EQ36328530-6ACF8670-C46E-4353-951C-9D6A7187E81DQ37182798-613777D3-A92D-45A3-911C-42B21A7474E9Q37212217-0C7008DD-E7F4-4977-BD8C-601E68C62BFDQ37447470-BE10B8AA-1C60-454B-85E5-F1943549D74BQ38163612-FE1FD49E-865B-4301-AAB5-F3D8499C42A8Q38879903-091C90ED-23A4-4954-8A48-D6C1BAC12A66Q39453236-51AB3352-8292-47D9-9714-BA65ABE77592Q41763780-161CC544-82ED-43A2-B08A-65CBE70BAB57Q42183828-7BFA161A-23F9-4628-8195-DB1D63F97F2AQ46983610-238D7E4E-5EF7-4638-92AC-C417D805969C
P2860
Induction of PPARbeta and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARbeta.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Induction of PPARbeta and pros ...... of PGI2 to activate PPARbeta.
@en
Induction of PPARbeta and prostacyclin
@nl
type
label
Induction of PPARbeta and pros ...... of PGI2 to activate PPARbeta.
@en
Induction of PPARbeta and prostacyclin
@nl
prefLabel
Induction of PPARbeta and pros ...... of PGI2 to activate PPARbeta.
@en
Induction of PPARbeta and prostacyclin
@nl
P2093
P2860
P1433
P1476
Induction of PPARbeta and pros ...... e of PGI2 to activate PPARbeta
@en
P2093
Horst Schweer
Markus Rieck
Mihaela Kreutzer
Sabine Müller-Brüsselbach
Tanja Fauti
Wolfgang Meissner
P2860
P304
P356
10.1111/J.1742-4658.2005.05055.X
P407
P577
2006-01-01T00:00:00Z